跳转至内容
Merck

I7378

Sigma-Aldrich

吲哚美辛

98.5-100.5% (in accordance with EP), powder or crystals, COX inhibitor

别名:

1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-3-吲哚乙酸

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C19H16ClNO4
CAS号:
分子量:
357.79
Beilstein:
497341
EC號碼:
MDL號碼:
分類程式碼代碼:
12161501
PubChem物質ID:
NACRES:
NA.77

product name

吲哚美辛, 98.5-100.5% (in accordance with EP)

生物源

synthetic

品質等級

化驗

98.5-100.5% (in accordance with EP)

形狀

powder or crystals

損耗

≤0.5% loss on drying

mp

158-162 °C

作用方式

enzyme | inhibits

SMILES 字串

COc1ccc2n(c(C)c(CC(O)=O)c2c1)C(=O)c3ccc(Cl)cc3

InChI

1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)

InChI 密鑰

CGIGDMFJXJATDK-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

吲哚美辛是环加氧酶1和2的抑制剂。吲哚美辛可对胃肠道、肾脏和大脑产生副作用。吲哚美辛与布洛芬一起使用,可有效治疗患有呼吸窘迫综合征的婴儿的动脉导管未闭(PDA)。吲哚美辛直肠给药可有效治疗内镜下逆行胰胆管造影(ERCP)诱发的胰腺炎。

應用

吲哚美辛已被用于:
  • 在人骨髓干细胞的成骨和脂肪形成分化测定中作为培养基补充剂
  • 作为牛羊水干细胞(BAFSCs)培养的培养基补充剂
  • 抑制T细胞的前列腺素E2(PGE2)生成

生化/生理作用

环加氧酶 (COX) 抑制剂,对 COX-1 的选择性相对较高。

特點和優勢

《受体分类和信号转导》手册的 前列腺素类受体 页面有该化合物的介绍。想要浏览手册的其他页面, 请单击此处
该化合物是ADME Tox研究的特色产品。点击此处 ,查看更多ADME Tox精选产品。想要了解有关生物活性小分子在其他研究领域应用的更多信息,请访问 sigma.com/discover-bsm

象形圖

Skull and crossbones

訊號詞

Danger

危險聲明

危險分類

Acute Tox. 1 Oral

儲存類別代碼

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus
Van Overmeire B, et al.
The New England Journal of Medicine, 343(10), 674-681 (2000)
Therapeutic potential of amniotic fluid stem cells to treat bilateral ovarian dystrophy in dairy cows in a subtropical region
Chang LB, et al.
Reproduction in domestic animals = Zuchthygiene, 53(2), 433-441 (2018)
Effectiveness of the use of Rectal Indometacin in the prevention of post-CPRE pancreatitis in the Naval Medical Center.
Islava EE, et al.
INTERNATIONAL JOURNAL OF ADVANCED MULTIDISCIPLINARY RESEARCH, 5(11), 44-51 (2018)
Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles
van den Akker F, et al.
Heliyon, 4(6), e00642-e00642 (2018)
Modulation of miRNAs by Vitamin C in Human Bone Marrow Stromal Cells
Kolhe R, et al.
Nutrients, 10(2), 186-186 (2018)

商品

Protein-based drug transporters are expressed in Sf9 cells. Understanding the specific mechanisms of tumor cell transporters is an essential aspect of chemotherapeutic drug design.

Discover Bioactive Small Molecules for ADME/Tox

实验方案

TrueGel3D® Hydrogel Plate protocol guides high-throughput culture of human adipose MSCs for screening applications.

相关内容

Protein-based drug transporters are found in most tissues including liver, kidney, intestine, and brain. These transporters are particularly important in cancer treatment and multi-drug resistance research. Understanding the specific mechanisms of tumor cell transporters is becoming an essential aspect of chemotherapeutic drug design.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门